Sfoglia per AUTORE
PANZUTO F
Collezione AO Ordine Mauriziano

  

Items : 4

Optimising Radioligand Therapy for Patients with Gastro-Entero-Pancreatic Neuroendocrine Tumours: Expert Opinion from an Italian Multidisciplinary Group. in Advances in therapy / Adv Ther. 2024 Jan;41(1):113-129. doi: 10.1007/s12325-023-02714-8. Epub 2023 Nov 21.
2024
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Stasi M; Volante M; Seregni E; Santimaria M; Schillaci O; Panzuto F; Milione M; Grimaldi F; Giordano A; D'Onofrio M; Ferone D; Bartolomei M; Berruti A; Foglia E; Falconi M; Fazio N; Lastoria S; Fazio N; Falconi M; Foglia E; Bartolomei M; Berruti A; D'Onofrio M; Ferone D; Giordano A; Grimaldi F; Milione M; Panzuto F; Santimaria M; et alii...

Prognostic significance of laterality in lung neuroendocrine tumors. in Endocrine / Endocrine. 2022 Jun;76(3):733-746. doi: 10.1007/s12020-022-03015-w. Epub 2022 Mar 18.
2022
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Ambrosio MR; Venuta F; Isidori A; Appetecchia M; Romero C; Volante M; Giannetta E; Panzuto F; Mancini M; Mazzilli R; Razzore P; Sesti F; Feola T; Baldelli R; Parlagreco E; Rinzivillo M; Puliani G; Trevisi E; Trabalza Marinucci B; Zanata I; Audisio A; Modica R; Bassi M; Verrico M; Siciliani A; Persano I; La Salvia A; Zatelli MC; Ibrahim M; et alii...

Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine Tumors. in JAMA network open / JAMA Netw Open. 2022 Feb 1;5(2):e220290. doi: 10.1001/jamanetworkopen.2022.0290.
2022
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Modica R; Andreasi V; Spada F; Severi S; Bracigliano A; Ambrosio MR; Zanata I; Puliafito I; Lamberti G; Cingarlini S; Rocca PA; Pignata SA; Rinzivillo M; Persano I; Versari A; Bongiovanni A; Lastoria S; Maccauro M; Seregni E; Di Maio M; Porcu L; Giacomelli L; Ricci C; Corti F; Perfetti V; Cirillo F; Grimaldi F; Cives M; Bajetta E; et alii...

Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues. in Gastroenterology / Gastroenterology. 2018 Aug;155(2):479-489.e7. doi: 10.1053/j.gastro.2018.04.010. Epub 2018 Apr 13.
2018
AO Cuneo
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Mazzaferro V; Buzzoni R; Delle Fave G; Giacomelli L; Milione M; Lo Russo G; Concas L; Femia D; Prinzi N; Garattini SK; Bajetta E; Tafuto S; Di Costanzo F; Torniai M; Zaniboni A; Ortolani S; Puliafito I; Panzuto F; Colao A; Brighi N; La Salvia A; Cavalcoli F; Bongiovanni A; Fazio N; Ricci S; Duro M; Davì MV; Cauchi C; Carnaghi C; et alii...